BioSpace News Archive

Selecta Biosciences, Inc. (NASDAQ: SELB) today announced that it plans to host a conference call on Thursday, May 4, 2023, at 8:30 a.m. ET to discuss its financial results for the first quarter ended March 31, 2023 and provide a business update.

The board of directors of Semler Scientific, Inc., is pleased to announce that it has appointed Doug Murphy-Chutorian, M.D., former CEO and a current member of the board of directors as chief executive officer on an interim basis with immediate effect.

Biodexa Pharmaceuticals PLC announces its audited preliminary results for the year ended 31 December 2022.

Biophytis SA announced that it has received written notification from the Nasdaq Stock Market LLC dated April 24, 2023, indicating that, based on the reported stockholders’ equity of of Biophytis as reported in its 20-F, the Company does not meet the minimum shareholders’ equity criteria of $2,500,000 in stockholders’ equity for continued listing.

How do state laws affect male infertility treatment? How does treatment vary across the country? What is ADAM and what are the results of its first clinical trials?

Astria Therapeutics, Inc. today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibit Deficiency and Angioedema Workshop in Budapest, Hungary.

A new special report published in the American Journal of Obstetrics and Gynecology provides a groundbreaking approach to preeclampsia, one of the most pressing issues in maternal health and will translate the prediction of risk into prevention of disease.

ENDRA Life Sciences Inc. announced today that it has priced an underwritten public offering of 3,750,000 shares of its common stock and warrants to purchase 1,875,000 shares of its common stock.

GeneDx today announced that its board of directors has approved a 1-for-33 reverse stock split of the Company’s Class A common stock.

Which YouTube videos can you trust talking about penile augmentation? Has the average size of a penis increased? Are there meaningful differences in drug choice for men with coronary artery disease and erectile dysfunction?